Literature DB >> 10529209

A Watson-Crick base-pair-disrupting methyl group (m1A9) is sufficient for cloverleaf folding of human mitochondrial tRNALys.

M Helm1, R Giegé, C Florentz.   

Abstract

We have previously shown by chemical and enzymatic structure probing that, opposite to the native human mitochondrial tRNA(Lys), the corresponding in vitro transcript does not fold into the expected tRNA-specific cloverleaf structure. This RNA folds into a bulged hairpin, including an extended amino acid acceptor stem, an extra large loop instead of the T-stem and loop, and an anticodon-like domain. Hence, one or several of the six modified nucleotides present in the native tRNA are required and responsible for its cloverleaf structure. Phylogenetic comparisons as well as structural analysis of variant transcripts had pointed to m(1)A9 as the most likely important modified nucleotide in the folding process. Here we describe the synthesis of a chimeric tRNA(Lys) with m(1)A9 as the sole modified base and its structural analysis by chemical and enzymatic probing. Comparison of this structure to that of the unmodified RNA, the fully modified native tRNA, and a variant designed to mimic the effect of m(1)A9 demonstrates that the chimeric RNA folds indeed into a cloverleaf structure that resembles that of the native tRNA. Thus, due to Watson-Crick base-pair disruption, a single methyl group is sufficient to induce the cloverleaf folding of this unusual tRNA. This is the first direct evidence of the role of a modified nucleotide in RNA folding.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10529209     DOI: 10.1021/bi991061g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  95 in total

1.  Chemical incorporation of 1-methyladenosine into oligonucleotides.

Authors:  Sergey N Mikhailov; Jef Rozenski; Ekaterina V Efimtseva; Roger Busson; Arthur Van Aerschot; Piet Herdewijn
Journal:  Nucleic Acids Res       Date:  2002-03-01       Impact factor: 16.971

2.  Quick two-step RNA ligation employing periodate oxidation.

Authors:  Shinya Kurata; Takashi Ohtsuki; Tsutomu Suzuki; Kimitsuna Watanabe
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

3.  Functional annotation of class I lysyl-tRNA synthetase phylogeny indicates a limited role for gene transfer.

Authors:  Alexandre Ambrogelly; Dragana Korencic; Michael Ibba
Journal:  J Bacteriol       Date:  2002-08       Impact factor: 3.490

Review 4.  Mitochondrial tRNA 3' end metabolism and human disease.

Authors:  Louis Levinger; Mario Mörl; Catherine Florentz
Journal:  Nucleic Acids Res       Date:  2004-10-11       Impact factor: 16.971

5.  Atypical archaeal tRNA pyrrolysine transcript behaves towards EF-Tu as a typical elongator tRNA.

Authors:  Anne Théobald-Dietrich; Magali Frugier; Richard Giegé; Joëlle Rudinger-Thirion
Journal:  Nucleic Acids Res       Date:  2004-02-10       Impact factor: 16.971

6.  Kinetics of tRNA folding monitored by aminoacylation.

Authors:  Hari Bhaskaran; Annia Rodriguez-Hernandez; John J Perona
Journal:  RNA       Date:  2012-01-27       Impact factor: 4.942

Review 7.  tRNA biology charges to the front.

Authors:  Eric M Phizicky; Anita K Hopper
Journal:  Genes Dev       Date:  2010-09-01       Impact factor: 11.361

8.  Alcohol-induced S-adenosylhomocysteine accumulation in the liver sensitizes to TNF hepatotoxicity: possible involvement of mitochondrial S-adenosylmethionine transport.

Authors:  Zhenyuan Song; Zhanxiang Zhou; Ming Song; Silvia Uriarte; Theresa Chen; Ion Deaciuc; Craig J McClain
Journal:  Biochem Pharmacol       Date:  2007-05-10       Impact factor: 5.858

9.  Trmt61B is a methyltransferase responsible for 1-methyladenosine at position 58 of human mitochondrial tRNAs.

Authors:  Takeshi Chujo; Tsutomu Suzuki
Journal:  RNA       Date:  2012-10-24       Impact factor: 4.942

10.  Pathogenic mechanism of a human mitochondrial tRNAPhe mutation associated with myoclonic epilepsy with ragged red fibers syndrome.

Authors:  Jiqiang Ling; Hervé Roy; Daoming Qin; Mary Anne T Rubio; Juan D Alfonzo; Kurt Fredrick; Michael Ibba
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.